
Overview
Medventure Spółka Z Ograniczoną Odpowiedzialnością Alternatywna Spółka Inwestycyjna is a venture capital fund that invests in research and development projects in the MedTech sector, focusing on areas such as telemedicine systems, AI algorithms for medical decision support, disease diagnosis, and modern drugs and vaccines. The fund has an investment budget of 40 million PLN and provides extensive support, including know-how and contacts, to help develop projects with global market potential.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
6 of 6 financial statements were filed late (the longest delay 370 days for 2021). All were audited by a statutory auditor.
- 202516/10/2026
- 202403/02/2026
- 202319/07/2024
- 202227/09/2023
- 202120/07/2023
- 202023/09/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
Websites
- medventure.vcMedVenture – fundusz venture capital z sektora MedTechWordPress 6.8ElementorGoogle AnalyticsGoogle Tag ManagerYoast SEOApache
General partners
Manner of representation
The general partner has the right to represent the company individually, including performing all judicial and extrajudicial acts. The sole general partner of the company is MEDVENTURE limited liability company with its registered office in Lublin, in which: in the case of a one-person management board, the President of the Management Board is authorised to make declarations on behalf of the company; in the case of a two-person management board, two members of the management board acting jointly are authorised to make declarations of will; in the case of a three-person management board, two members of the management board acting jointly are authorised to make declarations on behalf of the company; in the case of a four-person management board, three members of the management board acting jointly are authorised to make declarations on behalf of the company.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
PRP Analytics sp. z o.o. | 540.25 USD | 20% | ||
Phantombody sp. z o.o. | 459.21 USD | 25.3731% | ||
Woundscanning sp. z o.o. | 459.21 USD | 25.3731% |
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Mar 24, 2026 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Radix Advisors sp. z o.o. | $1,230,819.85 | radix-vc.com | ||
| Hard2beat sp. z o.o. | $477,577.77 | hard2beat.vc | ||
| Leonarto Vc sp. k. | $423,647.07 | leonarto.vc | ||
| Pomerangels Asi S.A. | $405,216.77 | pomerangels.com | ||
| Nunatak Capital S.K.A. | $332,413.19 | nunatakcapital.com | ||
| Knowledgehub Starter sp. z o.o. | $284,933.89 | kh.vc | ||
| Brave Seed Fund Kujawsko-Pomorski Fundusz Kapitałowy sp. z o.o. + limited partnership | $231,880.37 | brave.vc | ||
| Movens Venture Capital 1 S.K.A. | $201,217.25 | movenscapital.com | ||
| Scanderia Venture sp. z o.o. | $198,970.37 | scanderiaventure.com | ||
| Aligo Alfa sp. z o.o. | $185,657.60 | aligo.vc |
Change history
| Date | Event | |
|---|---|---|
| 2026-07-31 | Share capital reduction (167,972.00 PLN → 166,734.00 PLN) | |
| 2026-04-22 | Name change (Medventure Spółka Z Ograniczoną Odpowiedzialnością Alternatywna Spółka Inwestycyjna → Medventure) | |
| 2026-04-22 | Switch to PKD 2025 (1 PKD 2007 code → 2 PKD 2025 codes) | |
| 2024-05-14 | Share capital increase (147,121.00 PLN → 167,972.00 PLN) | |
| 2024-03-26 | Share capital increase (124,062.00 PLN → 147,121.00 PLN) |
FAQ
Last updated: 2026-10-19